Trelegy Ellipta is now approved for the maintenance treatment of asthma in patients aged 18 years and older. Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.
Rhinitis is an irritation or inflammation of the nasal mucous membranes. It can be caused by infectious pathogens, irritants, or allergens. Allergic rhinitis (AR), which is triggered by allergens such as dust, mold, and pollen, is the most common form, affecting 10% to 30% of persons worldwide.1 In the United States, this translates to approximately…